Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bob Geng

Safety of 300IR 5-Grass Tablet in Grass Pollen–Allergic Children With or Without Controlled Asthma: Further Data From a Post-Marketing Observational Study

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Utility of Minor Determinants in Penicillin Allergy Skin Testing

World Allergy Organization Journal

English

Related publications

Efficiacy of Injection Specific Immunotherapy for Grass Pollen Seasonal Allergic Rhinitis

World Allergy Organization Journal

English

Evaluation of the Frequency and Severity of Seasonal Allergic Rhinoconjunctivitis Caused by Grass Pollen in Children With Hazelnut Sensitization

Clinical and Translational Allergy

English

Implementation of Pre-Seasonal Sublingual Immunotherapy With a Five-Grass Pollen Tablet During Optimal Dosage Assessment

Clinical and Experimental Allergy

Allergy

Immunology

2009

English

Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

The Sensitization Model and Correlation of Bermuda Grass and Timothy Grass Pollen Allergen in Respiratory Allergic Diseases Patients in Southern China

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2016

English

Sustained Efficacy and Safety of a 300IR Daily Dose of a Sublingual Solution of Birch Pollen Allergen Extract in Adults With Allergic Rhinoconjunctivitis: Results of a Double-Blind, Placebo-Controlled Study

Clinical and Translational Allergy

English

A Polysaccharide From the Pollen of Timothy Grass (Phleum Pratense)

Biochemical Journal

1932

English

Prs53 - Cost-Utility Analysis of Sq® HDM Slit-Tablet in Patients With House Dust Mite Allergic Rhinitis With or Without Allergic Asthma in Poland

English

Economic Evaluation of SQ-standardized Grass Allergy Immunotherapy Tablet (Grazax®) in Children

ClinicoEconomics and Outcomes Research

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bob Geng

Safety of 300IR 5-Grass Tablet in Grass Pollen–Allergic Children With or Without Controlled Asthma: Further Data From a Post-Marketing Observational Study

Utility of Minor Determinants in Penicillin Allergy Skin Testing

Related publications

Efficiacy of Injection Specific Immunotherapy for Grass Pollen Seasonal Allergic Rhinitis

Evaluation of the Frequency and Severity of Seasonal Allergic Rhinoconjunctivitis Caused by Grass Pollen in Children With Hazelnut Sensitization

Implementation of Pre-Seasonal Sublingual Immunotherapy With a Five-Grass Pollen Tablet During Optimal Dosage Assessment

Dupilumab Suppresses Inflammatory Biomarkers in Asthma Patients With or Without Allergic Rhinitis: Post Hoc Analysis of the LIBERTY ASTHMA QUEST Study

The Sensitization Model and Correlation of Bermuda Grass and Timothy Grass Pollen Allergen in Respiratory Allergic Diseases Patients in Southern China

Sustained Efficacy and Safety of a 300IR Daily Dose of a Sublingual Solution of Birch Pollen Allergen Extract in Adults With Allergic Rhinoconjunctivitis: Results of a Double-Blind, Placebo-Controlled Study

A Polysaccharide From the Pollen of Timothy Grass (Phleum Pratense)

Prs53 - Cost-Utility Analysis of Sq® HDM Slit-Tablet in Patients With House Dust Mite Allergic Rhinitis With or Without Allergic Asthma in Poland

Economic Evaluation of SQ-standardized Grass Allergy Immunotherapy Tablet (Grazax&reg;) in Children

Economic Evaluation of SQ-standardized Grass Allergy Immunotherapy Tablet (Grazax®) in Children